Table 1 The effect of AGME on MDA level, % inhibition of O₂⁻, GPx activity, and MAO-A,B activities of cerebral cortex and striatum areas of mice after MPTP treatment

2.22 ± 0.26

1.53 ± 0.56

16.48 ± 2.14

19.87 ± 1.99

18.45 ± 1.70

20.87 ± 1.68

3.00 ± 1.01

2.73 ± 1.05

5.01 ± 1.01

6.34 ± 0.41^a

5.96 ± 0.22^a

5.16 ± 1.46^a

8.32 ± 1.10^a

5.09 ± 2.27^a

6.54 ± 2.04^a

9.02 ± 1.00^a

10.13 ± 1.18^a

15.00 ± 1.04^a

2.81 ± 0.48^b

1.70 ± 0.13^b

13.08 ± 1.95^b

11.87 ± 2.03^b

15.92 ± 0.81^b

13.41 ± 1.61^b

5.46 ± 0.67^b

6.16 ± 1.25^a

10.46 ± 0.67^b

2.93 ± 0.41

4.77 ± 0.15

10.85 ± 1.55

9.98 ± 2.55

6.19 ± 1.81

7.83 ± 0.93

8.51 ± 1.19

9.56 ± 1.34

11.51 ± 1.19

2.12 ± 0.43^b

3.75 ± 0.12^b

12.05 ± 1.99^b

14.04 ± 2.26^b

10.55 ± 1.18^b

12.37 ± 1.15^b

5.86 ± 0.68^b

6.70 ± 0.57 ^b

10.86 ± 0.68^b

2.01 ± 0.35^b

0.17 ± 0.19 ^b

15.75 ± 1.13^b

18.14 ± 1.26^b,c

16.54 ± 1.16^b

18.71 ± 1.26^b,c

4.21 ± 0.52^b

3.42 ± 0.72^b,c

6.21 ± 0.53^b,c